This study is looking at how blood sugar levels change in young people (ages 6-25) with cystic fibrosis (CF) when they have a pulmonary exacerbation (PEx), which is a flare-up of their lung symptoms. Researchers will use continuous glucose monitoring (CGM) to track blood sugar changes during these flare-ups, whether you're in the hospital or seen in the clinic. The goal is to see if blood sugar changes are greater during a PEx compared to when you're feeling better, and if these changes are linked to how you're feeling and if you need more antibiotics. This is an observational study, meaning no specific interventions are being tested. The study plans to enroll 50 participants and is currently unclear on its recruitment status.

Study design

This is an observational study that plans to enroll 50 participants. It will look at changes in blood sugar levels over time.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Blood sugar changes will be measured at 14 days after a pulmonary exacerbation.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.